Cargando…
Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
Parkinson’s disease (PD) is a common neurodegenerative disease in middle-aged and elderly individuals. At present, no effective drug has been developed to treat PD. Although a variety of drugs exist for the symptomatic treatment of PD, they all have strong side effects. Most studies on PD mainly foc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242205/ https://www.ncbi.nlm.nih.gov/pubmed/34220434 http://dx.doi.org/10.3389/fnins.2021.678154 |